Results: 10
Acknowledgement to Referees.
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 701, doi. 10.1007/s40259-020-00455-6
- Publication type:
- Article
Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration.
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 763, doi. 10.1007/s40259-020-00453-8
- By:
- Publication type:
- Article
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption.
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 783, doi. 10.1007/s40259-020-00452-9
- By:
- Publication type:
- Article
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease.
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 713, doi. 10.1007/s40259-020-00451-w
- By:
- Publication type:
- Article
Checkpoint Inhibitors in Gynecological Malignancies: Are we There Yet?
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 749, doi. 10.1007/s40259-020-00450-x
- By:
- Publication type:
- Article
The Immunotherapy Landscape in Renal Cell Carcinoma.
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 733, doi. 10.1007/s40259-020-00449-4
- By:
- Publication type:
- Article
Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 705, doi. 10.1007/s40259-020-00448-5
- By:
- Publication type:
- Article
Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 723, doi. 10.1007/s40259-020-00446-7
- By:
- Publication type:
- Article
European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice.
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 797, doi. 10.1007/s40259-020-00440-z
- By:
- Publication type:
- Article
Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study.
- Published in:
- BioDrugs, 2020, v. 34, n. 6, p. 809, doi. 10.1007/s40259-020-00447-6
- By:
- Publication type:
- Article